on semaglutide Some people are overdosing semaglutide, FDA warns | What you should know 1 Month On Semaglutide :

Ready for an effective weight loss program without needles

According to altRx's own disclosure, compounded GLP-1 medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality

An NPR report from February 2026 explored the benefits and risks of using GLP-1 medications at a normal BMI, noting that the long-term effects of these drugs in normal-weight populations are not well studied

Thats because Ozempic can cause rapid weight loss, which can be particularly visible in a persons face

Pratter, inheriting a rapidly expanding docket that has grown from 55 initial cases to over 1,882 pending actions as of June 2025